Cumulus Oncology
Edinburgh · Founded 2017
About Cumulus Oncology
Cumulus Oncology develops anti-cancer therapies for clinical settings in areas of high unmet need. We target key pathways to improve the efficacy and outcomes of current and experimental therapies. Cumulus has the backing of a successful entrepreneur in the oncology field and is led by a team of senior professionals and industry partners from across the drug discovery and development sector. Together, we offer a wealth of experience and deep insights into optimum approaches for improved cancer patient outcomes.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $17.0M
- Funding stage: Seed
- Last round: Seed (Jan 2024)
- Website: cumulusoncology.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cumulus-oncology-152672 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.